Article Text

Download PDFPDF
Antibiotic prophylaxis in cardiac surgery
  1. Graeme MacLaren1,
  2. Siang Fei Yeoh2,
  3. Denis Spelman3
  1. 1
    Cardiothoracic Intensive Care Unit, National University Hospital, Singapore
  2. 2
    Department of Pharmacy, National University Hospital, Singapore
  3. 3
    Department of Infectious Diseases and Microbiology, The Alfred Hospital, Melbourne, Australia
  1. Graeme MacLaren, Cardiothoracic Intensive Care Unit, National University Hospital, Singapore; gmaclaren{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor: The recent study by Dhadwal et al1 has a number of weaknesses which merit discussion. The study appears to have been initiated by a “perceived increase in crude infection rates” but the organisms responsible for this increase were not presented. Unless there was a high incidence of infection with resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) prior to study commencement, the routine use of vancomycin in a multi-drug …

View Full Text


  • Competing interests: None declared.